Sat.Jul 08, 2023 - Fri.Jul 14, 2023

article thumbnail

Unlicensed and off-label drugs: What do we know?

Drug Discovery World

Following the death of a cancer patient after they were given an unlicensed drug, Diana Spencer unpacks the practice of prescribing unlicensed and off-label medicines. This month, a cancer patient died and three others were hospitalised in the UK after they were administered an unlicensed version of the chemotherapy drug cabazitaxel. In a statement, the company at fault claimed the problem was caused by an issue at its medicines manufacturing unit.

Drugs 94
article thumbnail

First nonprescription birth control pill approved by FDA

Bio Pharma Dive

The oral contraceptive’s maker, Perrigo, said the pill will be available in drug and grocery stores early next year, but did not disclose its planned price.

Drugs 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lonely People’s Brains Work Differently, New Evidence Shows

AuroBlog - Aurous Healthcare Clinical Trials blog

Being surrounded by people who don’t see the world quite like you do increases your risk of feeling lonely, even if you’re friends with them. Neuroimaging tests on 66 young adults discovered significant contrasts in the way lonely people’s brains process information compared to their peers.

Research 190
article thumbnail

Cingulate prepares for FDA approval for its once-daily ADHD pill

Pharmaceutical Technology

To that end, the company presented positive top-line Phase III results for its once-daily stimulant for ADHD.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Actimed plans trials to treat muscle wasting syndrome in cancer patients

Pharmaceutical Technology

The company aims to start two trials in H1 2024 based on its current timeline, depending on if it closes its Series B round soon.

Trials 130
article thumbnail

AI May Have Found The Most Powerful Anti-Aging Molecule Ever Seen

AuroBlog - Aurous Healthcare Clinical Trials blog

Finding new drugs – called “drug discovery” – is an expensive and time-consuming task. But a type of artificial intelligence called machine learning can massively accelerate the process and do the job for a fraction of the price.

Drugs 202

More Trending

article thumbnail

Disturbing New Finding Links Cognitive Decline to Dental Hygiene

AuroBlog - Aurous Healthcare Clinical Trials blog

Researchers in Japan found a connection between tooth loss, gum disease, and shrinkage in a region of the brain involved in memory and Alzheimer’s disease called the hippocampus.

Research 219
article thumbnail

Startup Tenpoint raises $70M to develop regenerative medicines for the eye

Bio Pharma Dive

Backed by F-Prime Capital and Sofinnova Partners, the company claims to have technology that could allow it replace eye cells destroyed in age-related and inherited ocular conditions.

Medicine 234
article thumbnail

NVIDIA invests $50m in AI-enabled drug discovery

Pharmaceutical Technology

NVIDIA signed an investment and collaboration agreement with Recursion to create AI models to accelerate drug discovery.

Drugs 246
article thumbnail

July 13, 2023: Adrian Hernandez Shares Insights Into Driving Change to Promote Data Sharing

Rethinking Clinical Trials

Dr. Adrian Hernandez At the NIH Pragmatic Trials Collaboratory Steering Committee Meeting in May, we interviewed Dr. Adrian Hernandez about how to better promote data sharing. Hernandez is a co–principal investigator of the program’s Coordinating Center and the executive director of the Duke Clinical Research Institute. “We have to change the incentive structure because we still have barriers for sharing data.

Trials 130
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Small Study Reveals How The Pandemic Impaired Babies’ Social Development And Behavior

AuroBlog - Aurous Healthcare Clinical Trials blog

The world changed for all of us when we were suddenly plunged into a pandemic in 2020. COVID sent us into a series of lockdowns in a bid to control the spread of the virus until a vaccine could be developed.

article thumbnail

European regulators probe suicide risk to Ozempic, other Novo drug Saxenda

Bio Pharma Dive

Three reports from Iceland spurred the EMA to evaluate whether certain Novo Nordisk drugs, including Ozempic, might cause thoughts of self harm.

article thumbnail

Imperial spinout wins £1.6m Innovate UK grant for NK cell therapies

Pharmaceutical Technology

Innovate UK’s New Cancer Therapeutics programme awarded the grant to the Imperial College spinout to support pre-clinical development.

article thumbnail

July 24, 2023: Bioethics Research Project Explores Data Sharing and Respect for Trial Participants

Rethinking Clinical Trials

Dr. Stephanie Morain At the NIH Pragmatic Trials Collaboratory Steering Committee’s annual meeting in May, Dr. Stephanie Morain discussed the results of a recent bioethics initiative to explore ethical considerations for data sharing in the context of pragmatic clinical trials. The project was supported by a supplemental grant award from the NIH through the NIH HEAL Initiative.

Trials 130
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Karnataka budget gives big booster shot to health & lifesciences start-ups with focus on infrastructure & innovation

AuroBlog - Aurous Healthcare Clinical Trials blog

Karnataka government has given a booster shot to health & startups in lifesciences with focus on infrastructure and innovation. Announcing an allocation of Rs. 14,950,496 crore for healthcare, state has called for the re-introduction of Yashashwini scheme to provide medical facilities to rural farmers with a grant of Rs. 300 crore.

article thumbnail

Avrobio halts gene therapy research and considers a sale

Bio Pharma Dive

The decision to explore “strategic alternatives” comes about six weeks after the company sold its most advanced treatment to Novartis for nearly $90 million.

article thumbnail

EMA concern stirs over suicide risk with weight loss GLP-1RA drugs

Pharmaceutical Technology

The EMA is reviewing data on the potential effects of high-profile GLP-1RAs in causing suicidal thoughts and thoughts of self-harm.

Drugs 242
article thumbnail

Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report

Fierce Pharma

Caught in a litigation crossfire, Moderna has reportedly opened two new fronts in its COVID-19 vaccine patent war with Pfizer and BioNTech. | Moderna has lodged two new lawsuits at the High Court in Dublin, Ireland, and the Brussels Commercial Court in Belgium, Juve Patent first reported. This adds to a complex web of ongoing mRNA patent litigation.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Staying Up All Night May Actually Relieve Depression in Some People

AuroBlog - Aurous Healthcare Clinical Trials blog

As most new parents can attest, sleepless nights don’t exactly make for the most cheerful mornings. This is why it makes little sense that total sleep deprivation temporarily resets the mood of nearly half of people with a major depressive disorder.

article thumbnail

EMA expands probe of possible suicide risk to popular weight loss, diabetes drugs

Bio Pharma Dive

The European drug regulator says it now has 150 reports of possible cases involving self-injury and suicidal thoughts among people taking GLP-1 medicines like Ozempic.

Drugs 245
article thumbnail

Iovance looks to advance its non-small cell lung cancer therapy

Pharmaceutical Technology

Iovance Biotherapeutics completes a preliminary analysis after the US' FDA found the trial design acceptable for accelerated approval.

Trials 189
article thumbnail

Novo Nordisk's GLP-1 drugs under review in Europe after reports flag possible suicide risks

Fierce Pharma

Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbust | Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbuster products.

Drugs 123
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Do clinical trials pay for travel?

Antidote

For medical research to advance, the participation of individuals in a clinical trial is essential. However, accessing trial sites can present an undue burden. A survey about barriers to clinical trial participation found that the primary reason patients declined to enroll in a study was due to the inconvenience associated with travel. This is backed up by research from Deloitte, which reveals that 70% of potential clinical trial participants in the United States live at least two hours away fro

article thumbnail

Lilly to buy Versanis, adding to obesity drug pipeline

Bio Pharma Dive

The pharma will pay up to $1.9 billion to acquire the private biotech and its experimental antibody, which Lilly plans to pair with its own weight loss medicines.

Antibody 246
article thumbnail

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Pharmaceutical Technology

Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.

Drugs 186
article thumbnail

Pharma Not the Only Ones Upset with PBM Practices

Pharmaceutical Commerce

The National Alliance of Healthcare Purchaser Coalitions releases resources for employers/health plan purchasers to offer insights on PBMs role in high prescription drug costs.

Drugs 98
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Quanterix’s LucentAD Test May Help with Early Diagnosis of Alzheimer’s

XTalks

Diagnostic test maker Quanterix has launched LucentAD, a biomarker-based prescription Alzheimer’s disease (AD) test to help in the diagnosis of the disease. The test is intended to help diagnose Alzheimer’s disease with other diagnostic tools. It is not intended as a standalone screening or diagnostic assay, according to Quanterix. LucentAD is designed to evaluate patients experiencing cognitive symptoms that indicate early signs of Alzheimer’s disease.

Protein 98
article thumbnail

Takeda withdraws FDA approval application for dengue vaccine

Bio Pharma Dive

While the shot is approved in the EU, Takeda wasn’t able to address data collection issues raised by the US regulator in its current review cycle.

article thumbnail

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Pharmaceutical Technology

Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.

130
130
article thumbnail

Boost Post vs Creating Ads on Facebook

Pharma Marketing Network

When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.